The latest dataset was made available in EQUIPP® as of May 12, 2023. This dataset now includes 6-month performance information based off of prescription drug claims from October 1, 2023 through March 31, 2023.
YTD Date Range: January 1, 2023 - March 31, 2023
NOTE:This will be the FIRST Year-to-Date Reporting period available with data for 2023.
Things to Know:
Webinar Recordings - Please visit our New Resource Materials Section for our most recently recorded webinars.
Influenza Performance Update:
The Influenza Vaccination measures is now available in EQUIPP® and will be tracked through the 2022-2023 flu season, with a final measurement date ending March 31, 2023. Note: This is the LAST update of immunization information for the 2022-2023 influenza season.
Current Influenza Immunization performance data date range:
June 1, 2022 - March 31, 2023
For more Immunization Measure information, please visit our immunization page of our website.
MEASURE YEAR 2023 PHARMACY QUALITY ALLIANCE:
All Pharmacy Quality Alliance measures in EQUIPP have been updated to match the MY2023 specifications as updated by the Pharmacy Quality Alliance.
Here are some notable changes:
- Tirzepatide (Mounjaro) has been added to Diabetes PDC and to Statin Use in Persons with Diabetes (SUPD)
- Oral cladribine has been revised to be a medication exclusion for Multiple Sclerosis PDC
- The combination of atorvastatin and ezetimibe has been added to Cholesterol PDC and to SUPD